Research Article| Volume 4, ISSUE 3, P310-317, June 2003

Download started.


Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry


      The objective of this study was to assess the safety of gabapentin (Neurontin) exposure in human pregnancy. Prospective and retrospective data concerning 51 fetuses, including 3 twin gestations, were collected from 39 women with epilepsy and other disorders exposed to gabapentin during pregnancy. Data were collected and evaluated about the 44 live births, including maternal demographics, diagnosis, treatment and complications, and fetal complications and outcomes. The results of this study showed that the rates of maternal complication, cesarean section, miscarriage, low birth weight, and malformation were less than or similar to those seen in the general population or among women with epilepsy. Gabapentin exposure during pregnancy did not lead to an increased risk for adverse maternal and fetal events in this study. However, because of the small number of patients examined in this study, additional data from more pregnancies and outcomes are needed.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • McLean M.J.
        Gabapentin in the management of convulsive disorders.
        Epilepsia. 1999; 40: S39-S50
        • Appleton R.
        • Fichtner K.
        • LaMoreaux L.
        • et al.
        Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study.
        Epilepsia. 1999; 40: 1147-1154
        • Backonja M.
        • Beydoun A.
        • Edwards K.
        • et al.
        Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
        JAMA. 1998; 280: 1831-1836
        • Botts R.
        • Raskind J.
        Gabapentin and lamotrigine in bipolar disorder.
        Am. J. Health-Syst. Pharm. 1999; 56: 1939-1944
        • Yerby M.S.
        Pregnancy and teratogenesis.
        in: Trimble M.R. Women and epilepsy. John Wiley and Sons, Ltd, 1991: 163-191
        • Morrell M.J.
        Guidelines for the care of women with epilepsy.
        Neurology. 1998; 51: S21-S27
      1. Lamictal [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2001

      2. Topamax [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical Inc; 1999

      3. Neurontin [package insert]. Morris Plains, NJ: Parke–Davis; 1998

      4. Trilepital [package insert]. East Hanover, NJ: Novartis; 2001

      5. Gabitril [package insert]. West Chester, PA: Cephalon; 2001

      6. Zonegran [package insert]. South San Francisco, CA. Elan; 2000

      7. Keppra [package insert]. Smyrna, GA. UCB Pharma, Inc.; 1999

        • Bruni J.
        Women’s issues in the treatment of epilepsy.
        Can. J. Neurol. Sci. 1998; 25: S19-S23
      8. Ventura SJ, Martin JA, Curtin SC, Menacker F, Hamilton E. Births: final data for 1999. Issued by: National Center for Health Statistics National Vital Statistics Reports; Hyattsville, MD; 2001. National Vital Statistics Reports 2001; 49(1):75,77, 83, and 85

        • Liporace J.D.
        Women’s issues in epilepsy: menses, childbearing, and more.
        Postgrad. Med. 1997; 102: 123-138
      9. Notzon FC, Komarov YM, Korotkova AV, et al. Maternal and child health statistics: Russian Federation and United States, selected years 1985–95. Hyattsville, MD: National Center for Health Statistics; 1999. Vital Health Statistics, Series 5, No.10:29

        • Zahn C.A.
        • Morrell M.J.
        • Collins S.D.
        • Labiner D.M.
        • Yerby M.S.
        Management issues for women with epilepsy: a review of the literature.
        Neurology. 1998; 51: 949-956
      10. Menacker F, Curtin SC. Trends in cesarean birth and vaginal birth after previous Cesarean, 1991–1999. Hyattsville, MD: National Center for Health Statistics, 2001. Vital Health Statistics, vol 49, No.13:2

        • Crawford P.
        CPD-education and self-assessment: epilepsy and pregnancy.
        Seizure. 2001; 10: 212-219
        • Tamer S.K.
        • Misra S.
        • Jaiswal S.
        The offspring of epileptic mother.
        Indian J. Pediatr. 1996; 63: 523-531
      11. Ventura SJ, Mosher WD, Curtin SC, Abma JC, Henshaw S. Trends in pregnancies and pregnancy rate outcome: estimates for the United States, 1976–1996. Hyattsville, MD: National Center for Health Statistics, 2000. Vital Health Statistics, Series 21, No. 56:10,16,17